NK1 receptor antagonists – are they really without effect in the pain clinic?
- 1 December 2000
- journal article
- other
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (12) , 462-464
- https://doi.org/10.1016/s0165-6147(00)01578-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pigPain, 2000
- NK1 (substance P) receptor antagonists – why are they not analgesic in humans?Published by Elsevier ,2000
- Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonistsTrends in Pharmacological Sciences, 1999
- Lanepitant, an NK-1 antagonist, in painful diabetic neuropathyClinical Pharmacology & Therapeutics, 1999
- The substance P receptor antagonist CP-99,994 reduces acute postoperative pain*Clinical Pharmacology & Therapeutics, 1998
- Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pigNeuroscience, 1998
- Investigation into species variants in tachykinin NK1 receptors by use of the non‐peptide antagonist, CP‐96,345British Journal of Pharmacology, 1991